Press Releases
August 14, 2025
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
August 6, 2025
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
July 31, 2025
Press release: Online availability of Sanofi’s half-year financial report for 2025
Upcoming Events
Past Events
31Jul
2025
Second Quarter 2025
Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation was followed by a Q&A session.
Quarterly results
24Apr
2025
First quarter 2025
First quarter 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Quarterly results
30Jan
2025
Fourth Quarter & Full Year 2024 Results
Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.
15:00 - 16:30 CET (9:00am – 10:30am EST)
Quarterly results